Institute for Cancer Research
Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.
The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.
Scientific director
Scientific production - Institute for Cancer Research
| PubMed articles | Doctoral theses | |
| 2010 | so far | so far |
| 2009 | 164 | 22 |
| 2008 | 140 | 11 |
| 2007 | 153 | 16 |
| 2006 | 171 | 12 |
| 2005 | 158 | 12 |
Print this page [56759 visits]Latest news
JBI Award for for "Best Paper in Translational Bioinformatics" to scientists from Department of Genetics
The Journal of Biomedical Informatics (JBI) Award for "Best Paper in Translational Bioinformatics" was given to a work entitled "Allele-specific copy number analysis of breast carcinomas" and originating from the Department of Genetics at the Institute for Cancer Research. Presenting author was Peter Van Loo (photo), visiting postdoctoral researcher at the Department of Genetics. Co-authors affiliated to the Oslo University Hospital were Silje Nordgard, Hege Russnes, Inga Rye, Bjørn Naume, Anne-Lise Børresen-Dale and Vessela Kristensen.
The ceremony took place during the annual international conference on "Intelligent Systems for Molecular Biology" (ISMB), which was held in Boston this summer. The ISMB 2010 is counted as the year’s most important computational biology event globally. This is the major meeting of the International Society for Computational Biology (ISCB).
Torsten Waldminghaus finds that surprising results of ChIP on Chip experiments are often false positives
In a currently published article in BMC Genomics, Torsten Waldminghaus and group leader Kirsten Skarstad from the Department of Cell Biology reveal a high number of false positives in ChIP on Chip experiments and develop a modified protocol.
Edgar Rivedal elected Chairperson of the IARC
Dr. Edgar Rivedal, head of the cell biology group at the Department of Cancer Prevention is elected Chairperson of the Scientifc Council of the "International Agency for Research on Cancer" (IARC).
The Scientific Council consists of scientists appointed as experts in cancer research, one from each of the 21 member states.
Aug 31, 2010
Oslo, September 20-22, 2010
Aug 30, 2010
Latest publications
Inst. for Cancer Research
Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study
BMC Cancer, 10 (1), 469 (in press)
PubMed 20809961
Predicted Risk of Radiation-Induced Cancers after Involved Field and Involved Node Radiotherapy with or without Intensity Modulation for Early-Stage Hodgkin Lymphoma in Female Patients
Int J Radiat Oncol Biol Phys (in press)
PubMed 20800383
Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density
Breast Cancer Res, 12 (4), R65 (in press)
PubMed 20799965
Selected publications
Journal Impact Factor > 5, first or last author from the Institute for Cancer Research
Radiosensitizing Drugs: Lessons to Be Learned From the Oxaliplatin Story
J Clin Oncol (in press)
PubMed 20733124
(Impact 17.8)
UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy
Autophagy, 6 (7) (in press)
PubMed 20724836
(Impact 6.8)
Autophagic degradation of an oncoprotein
Autophagy, 6 (7) (in press)
PubMed 20724820
(Impact 6.8)
